Leap Therapeutics
LPTX
LPTX
80 hedge funds and large institutions have $73.9M invested in Leap Therapeutics in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.04% more ownership
Funds ownership: 4.86% → 4.9% (+0.04%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
47% less capital invested
Capital invested by funds: $139M → $73.9M (-$65.1M)
Holders
80
Holding in Top 10
1
Calls
$563K
Puts
$85K
Top Buyers
| 1 | +$2.91M | |
| 2 | +$2.11M | |
| 3 | +$1.59M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.4M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.19M |
Top Sellers
| 1 | -$5.88M | |
| 2 | -$2.19M | |
| 3 | -$1.72M | |
| 4 |
SCM
Sio Capital Management
New York
|
-$1.43M |
| 5 |
PA
Perceptive Advisors
New York
|
-$919K |